ICON Total Current Liabilities 2010-2024 | ICLR
ICON total current liabilities from 2010 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- ICON total current liabilities for the quarter ending December 31, 2024 were $2.796B, a 1.03% decline year-over-year.
- ICON total current liabilities for 2024 were $2.796B, a 1.03% decline from 2023.
- ICON total current liabilities for 2023 were $2.826B, a 5.02% increase from 2022.
- ICON total current liabilities for 2022 were $2.691B, a 8.54% increase from 2021.
| ICON Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $2,796 |
| 2023 | $2,826 |
| 2022 | $2,691 |
| 2021 | $2,479 |
| 2020 | $1,124 |
| 2019 | $1,131 |
| 2018 | $611 |
| 2017 | $566 |
| 2016 | $494 |
| 2015 | $572 |
| 2014 | $538 |
| 2013 | $501 |
| 2012 | $413 |
| 2011 | $307 |
| 2010 | $250 |
| 2009 | $300 |
| ICON Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2,796 |
| 2024-09-30 | $2,819 |
| 2024-06-30 | $2,742 |
| 2024-03-31 | $2,946 |
| 2023-12-31 | $2,826 |
| 2023-09-30 | $2,871 |
| 2023-06-30 | $2,760 |
| 2023-03-31 | $2,899 |
| 2022-12-31 | $2,691 |
| 2022-09-30 | $2,731 |
| 2022-06-30 | $2,482 |
| 2022-03-31 | $2,541 |
| 2021-12-31 | $2,479 |
| 2021-09-30 | $2,301 |
| 2021-06-30 | $1,105 |
| 2021-03-31 | $1,080 |
| 2020-12-31 | $1,124 |
| 2020-09-30 | $1,243 |
| 2020-06-30 | $1,170 |
| 2020-03-31 | $1,209 |
| 2019-12-31 | $1,131 |
| 2019-09-30 | $729 |
| 2019-06-30 | $709 |
| 2019-03-31 | $712 |
| 2018-12-31 | $611 |
| 2018-09-30 | $602 |
| 2018-06-30 | $548 |
| 2018-03-31 | $628 |
| 2017-12-31 | $566 |
| 2017-09-30 | $527 |
| 2017-06-30 | $487 |
| 2017-03-31 | $516 |
| 2016-12-31 | $494 |
| 2016-09-30 | $458 |
| 2016-06-30 | $457 |
| 2016-03-31 | $566 |
| 2015-12-31 | $572 |
| 2015-09-30 | $910 |
| 2015-06-30 | $572 |
| 2015-03-31 | $559 |
| 2014-12-31 | $538 |
| 2014-09-30 | $536 |
| 2014-06-30 | $503 |
| 2014-03-31 | $500 |
| 2013-12-31 | $501 |
| 2013-09-30 | $476 |
| 2013-06-30 | $456 |
| 2013-03-31 | $427 |
| 2012-12-31 | $413 |
| 2012-09-30 | $384 |
| 2012-06-30 | $371 |
| 2012-03-31 | $371 |
| 2011-12-31 | $307 |
| 2011-09-30 | $291 |
| 2011-06-30 | $271 |
| 2011-03-31 | $291 |
| 2010-12-31 | $250 |
| 2010-09-30 | $263 |
| 2010-06-30 | $249 |
| 2010-03-31 | $275 |
| 2009-12-31 | $300 |
| 2009-09-30 | $320 |
| 2009-06-30 | $325 |
| 2009-03-31 | $283 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.429B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.904B | 28.19 |
| Elevance Health (ELV) | United States | $87.590B | 11.69 |
| CVS Health (CVS) | United States | $79.455B | 11.63 |
| Cencora (COR) | United States | $47.362B | 17.19 |
| DiDi Global (DIDIY) | China | $23.670B | 0.00 |
| Natera (NTRA) | United States | $20.908B | 0.00 |
| Revvity (RVTY) | United States | $13.985B | 23.45 |
| BioMerieux (BMXMF) | France | $13.758B | 0.00 |
| Viatris (VTRS) | United States | $13.595B | 4.19 |
| Doximity (DOCS) | United States | $13.537B | 70.40 |
| Solventum (SOLV) | United States | $13.178B | 0.00 |
| Avantor (AVTR) | United States | $11.895B | 17.47 |
| CochLear (CHEOY) | Australia | $11.072B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
| HealthEquity (HQY) | United States | $9.484B | 47.58 |
| Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
| Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
| Organon (OGN) | United States | $3.884B | 3.96 |
| Sotera Health (SHC) | United States | $3.814B | 20.40 |
| BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
| Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
| Concentras Parent (CON) | United States | $2.951B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
| Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Progyny (PGNY) | United States | $1.961B | 39.71 |
| Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Premier (PINC) | United States | $1.690B | 10.82 |
| Agilon Health (AGL) | United States | $1.500B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
| CareDx (CDNA) | United States | $1.146B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
| Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
| Embecta (EMBC) | United States | $0.798B | 5.47 |
| Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| MultiPlan (MPLN) | United States | $0.472B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
| DocGo (DCGO) | United States | $0.453B | 17.08 |
| InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
| Enhabit (EHAB) | United States | $0.406B | 35.09 |
| QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
| Nutex Health (NUTX) | United States | $0.314B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Beauty Health (SKIN) | United States | $0.194B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
| Biodesix (BDSX) | United States | $0.122B | 0.00 |
| So-Young (SY) | China | $0.116B | 19.63 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
| ModivCare (MODV) | United States | $0.071B | 3.85 |
| Oncology Institute (TOI) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |